Bonus Biogroup Ltd. - ROE
BBIXF
Price:
$0.095
Market Cap:
$297.82M
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is in phase III clinical trial, as well as in preclinical stage for the treatment of other inflammations and tissue damage, including chronic kidney dise...[Read more]
Industry
Biotechnology
IPO Date
2019-07-30
Stock Exchange
OTC
Ticker
BBIXF
PE Ratio
[-11.35]
ROE
[667.39%]
Current Ratio
[0.13]
Dividend Yield
[0%]
Enterprise Value
[306.49M]
Dividend History
The ROE as of July 2026 (TTM) for Bonus Biogroup Ltd. (BBIXF) is 667.39%
According to Bonus Biogroup Ltd.’s latest financial reports and current stock price. The company's current ROE is 667.39%. This represents a change of 176.63% compared to the average of 241.26% of the last 4 quarters.
Bonus Biogroup Ltd. (BBIXF) Historical ROE (quarterly & annually)
How has BBIXF ROE performed in the past?
The mean historical ROE of Bonus Biogroup Ltd. over the last ten years is 97.41%. The current 667.39% ROE has changed 585.17% with respect to the historical average. Over the past ten years (40 quarters), BBIXF's ROE was at its highest in in the March 2025 quarter at 378.15%. The ROE was at its lowest in in the December 2024 quarter at -84.23%.
Average
97.41%
Median
46.73%
Minimum
-399.97%
Maximum
589.71%
Bonus Biogroup Ltd. (BBIXF) ROE by Quarter and Year
Discovering the peaks and valleys of Bonus Biogroup Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 310.85%
Maximum Annual ROE = 589.71%
Minimum Annual Increase = -208.10%
Minimum Annual ROE = -399.97%
| Year | ROE | Change |
|---|---|---|
| 2025 | 432.38% | -208.10% |
| 2024 | -399.97% | 310.85% |
| 2023 | -97.35% | 41.84% |
| 2022 | -68.64% | -35.67% |
| 2021 | -106.69% | 48.66% |
| 2020 | -71.77% | -144.28% |
| 2019 | 162.09% | -72.51% |
| 2018 | 589.71% | 86.40% |
| 2017 | 316.37% | 45.17% |
| 2016 | 217.93% | -77.51% |
Bonus Biogroup Ltd. (BBIXF) Average ROE
How has BBIXF ROE performed in the past?
The current ROE of Bonus Biogroup Ltd. (BBIXF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-21.65%
5-year avg
-48.05%
10-year avg
97.41%
Bonus Biogroup Ltd. (BBIXF) ROE vs. Peers
How is BBIXF’s ROE compared to its peers?
Bonus Biogroup Ltd.’s ROE is greater than Starpharma Holdings Limited (-15.96%), greater than Finch Therapeutics Group, Inc. (-86.83%), greater than Resverlogix Corp. (6.67%), greater than Celyad Oncology S.A. (-242.11%), greater than Institute of Biomedical Research Corp. (-1825.86%), greater than Evolva Holding S.A. (-10.72%), greater than Cordlife Group Limited (-10.82%), greater than Zenith Capital Corp. (0%), greater than ImpediMed Limited (-165.13%), less than Cell Source, Inc. (22.48%),
| Company | ROE | Market cap |
|---|---|---|
| -15.96% | $216.03M | |
| -86.83% | $15.42M | |
| 6.67% | $22.19M | |
| -242.11% | $8.95M | |
| -1825.86% | $3.30M | |
| -10.72% | $15.50M | |
| -10.82% | $38.57M | |
| 0% | $7.99M | |
| -165.13% | $6.91M | |
| 22.48% | $37.08M |
Build a custom stock screener for Bonus Biogroup Ltd. (BBIXF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bonus Biogroup Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Bonus Biogroup Ltd. (BBIXF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Bonus Biogroup Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Bonus Biogroup Ltd.'s ROE?
How is the ROE calculated for Bonus Biogroup Ltd. (BBIXF)?
What is the highest ROE for Bonus Biogroup Ltd. (BBIXF)?
What is the 3-year average ROE for Bonus Biogroup Ltd. (BBIXF)?
What is the 5-year average ROE for Bonus Biogroup Ltd. (BBIXF)?
How does the current ROE for Bonus Biogroup Ltd. (BBIXF) compare to its historical average?